Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators

Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical, reproductive, lung, brain, and prostate cancers. However, resistance of cancer cells to CP chemotherapy has led to...

Full description

Saved in:

Bibliographic Details
Published in:	Cellular signalling Vol. 78; p. 109871
Main Authors:	Ashrafizadeh, Milad, Zarrabi, Ali, Hushmandi, Kiavash, Hashemi, Farid, Moghadam, Ebrahim Rahmani, Owrang, Marzieh, Hashemi, Fardin, Makvandi, Pooyan, Goharrizi, Mohammad Ali Sheikh Beig, Najafi, Masoud, Khan, Haroon
Format:	Journal Article
Language:	English
Published:	England Elsevier Inc 01.02.2021
Subjects:	Chemoresistance Cisplatin Long non-coding RNA Lung cancer MicroRNA HOTAIR TC-NER circRNAs TRIM Lung cancer JNK PTEN TAZ IL-22 ncRNAs NF-κB CAV-1 PI3K DLEU1 mTOR PBK SOX4 P-gp PAQR4 FGF EGCG MAPK NEAT1 FBXO11 EMT Long non-coding RNA SIRT3 ADAM19 CCAT1 MMP ZEB1 SNHG11 TDP-43 miR ROS AMPK UCA1 MALAT1 XIST GAS5 FGFRs CBLL1 HDAC ERK NPC ABC lncRNA SAMD9 Chemoresistance SDF-1 CXCR4 PARP mRNA cyt C AK4 MRP-1 CTR1 CSB CAFs TP53INP1 PCAT-1 3'-UTR TGF-β ATGs SCLC SNHG1 NORAD FZD7 STAT3 Akt MIAT CP Cisplatin LINC00707 Mcl-1 MicroRNA PLGA PTP1B
ISSN:	0898-6568, 1873-3913, 1873-3913
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!